BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
7.59
-0.24 (-3.07%)
At close: Dec 5, 2025, 4:00 PM EST
7.62
+0.03 (0.40%)
After-hours: Dec 5, 2025, 7:10 PM EST
BioCryst Pharmaceuticals Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$19.00
Upside
+150.33%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citizens | Citizens | Buy Maintains $27 → $25 | Buy | Maintains | $27 → $25 | +229.38% | Nov 5, 2025 |
| Barclays | Barclays | Hold Maintains $11 → $9 | Hold | Maintains | $11 → $9 | +18.58% | Nov 4, 2025 |
| Needham | Needham | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | +137.15% | Nov 4, 2025 |
| TD Cowen | TD Cowen | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +295.26% | Oct 15, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $24 → $26 | Buy | Maintains | $24 → $26 | +242.56% | Oct 15, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $17 → $27 | Buy | Maintains | $17 → $27 | +255.73% | Oct 15, 2025 |
| Needham | Needham | Strong Buy Maintains $17 → $20 | Strong Buy | Maintains | $17 → $20 | +163.50% | Oct 15, 2025 |
| Needham | Needham | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +123.98% | Aug 4, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $13 → $15 | Strong Buy | Maintains | $13 → $15 | +97.63% | Jul 1, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $13 | Buy | Reiterates | $13 | +71.28% | Jun 30, 2025 |
| Wedbush | Wedbush | Buy Maintains $16 → $18 | Buy | Maintains | $16 → $18 | +137.15% | Jun 30, 2025 |
| Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +123.98% | Jun 27, 2025 |
| Needham | Needham | Strong Buy Reiterates $17 | Strong Buy | Reiterates | $17 | +123.98% | Jun 25, 2025 |
| Barclays | Barclays | Hold Maintains $8 → $11 | Hold | Maintains | $8 → $11 | +44.93% | May 7, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $11 → $13 | Buy | Reiterates | $11 → $13 | +71.28% | May 6, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $10 → $13 | Buy | Maintains | $10 → $13 | +71.28% | May 6, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.